Screener
NovoCure NVCR Total Revenue
Total Revenue at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: NovoCure’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001645113-26-000062
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 | Year ended December 31, 2025 |
|---|---|---|---|---|---|
| Net revenues | $183,584 | $158,805 | $357,639 | $313,799 | $655,353 |
| Cost of revenues | 41,106 | 41,472 | 80,035 | 79,993 | 166,879 |
| Gross profit | 142,478 | 117,333 | 277,604 | 233,806 | 488,474 |
| Operating costs and expenses: | |||||
| Research, development and clinical studies | 51,448 | 55,833 | 109,784 | 109,610 | 224,544 |
| Sales and marketing | 61,684 | 57,066 | 120,041 | 112,858 | 240,064 |
| General and administrative | 39,908 | 43,955 | 125,761 | 88,724 | 177,666 |
| Total operating costs and expenses | 153,040 | 156,854 | 355,586 | 311,192 | 642,274 |
Item 1. Financial Statements
FAQ
- What is NovoCure's total revenue?
- NovoCure (NVCR) reported total revenue of $183.58M in Q2 2026.
- How has NovoCure's total revenue changed year-over-year?
- NovoCure's total revenue increased by 15.6% year-over-year, from $158.81M to $183.58M.
- What is the long-term trend for NovoCure's total revenue?
- Over 4 years (2021 to 2025), NovoCure's total revenue has grown at a 5.2% compound annual growth rate (CAGR), from $535.03M to $655.35M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about NovoCure's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude